OVERVIEW

38th Annual New Treatments in Chronic Liver Disease is organized by Scripps Conference Services & CME and will be held from Mar 16 - 17, 2024 at Coronado Island Marriott Resort & Spa, Coronado, California, United States of America.

Conference Overview:
This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real-world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.

Educational Objectives:
After attending this live activity, participants should be able to:
• Assess new therapies for curing Delta Hepatitis and Hepatitis B.
• Review guidelines for the management of cholestatic liver diseases.
• Outline recent advances in the understanding and management of ascites and hepatorenal syndrome.
• Evaluate drugs in development for metabolic liver disease.
• Address causes and trends of liver disease and liver transplantation in women.

KEY DATES

Event Start Date
16 Mar, 2024
Event Start Date
Event End Date
17 Mar, 2024
Event End Date
Credits

Physicians:
Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Scripps Health designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Points:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. credit.

Nurses and Nurse Practitioners:
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.

For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit(s)™ for attendance at structured learning activities offered by organizations accredited by the ACCME.

The American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

Physician Assistants:
PAs may claim a maximum of 10.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

Pharmacists:
The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 Credit(s)™.

  • 10.25 AMA PRA Category 1 Credits™
  • 10.25 MOC
  • 10.25 Credits
  • TARGET AUDIENCE

    PhysicianPharmacistPhysician AssistantStudentsResidentsNursesGastroenterologistsHepatologistsInfectious Diseases PhysicianNurse PractitionersFellows

    SPECIALITIES

    Gastroenterology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationCoronado Island Marriott Resort & Spa
    2000 2nd St

    RELATED CONFERENCES & LIVE WEBINARS